Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deutsch

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Seminars in Radiation Oncology|September 14, 2016
Successes and Failures of Combined Modality Therapies in Head and Neck CancerDaniel W Bowles, Eric Deutsch, David Raben
Plos One|January 31, 2015
Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migrationAdnan Arshad, Eric Deutsch, Marie-Catherine Vozenin
Medecine Sciences : M/S|April 24, 2026
[The radio-induced antitumor immune response as a therapeutic target]Valentin Monteiro, Michèle Mondini, Eric Deutsch, et al.
The Lancet. Oncology|April 3, 2025
Innovative, early-phase clinical trials of drug-radiotherapy combinationsAntonin Levy, Christophe Massard, Stefan Michiels, et al.
Internal and Emergency Medicine|September 10, 2015
Ultrasound guided chest tube placement for basilar pneumothoraxEric Deutsch, Sierra Beck, Jehangir Meer, et al.
Lancet (London, England)|January 6, 2018
Concerns about cardiotoxicity in the HERA trialAntonin Levy, Cyrus Chargari, Eric Deutsch, et al.
Oncoimmunology|November 26, 2024
Heterogeneous intratumor irradiation: a new partner for immunotherapyPaul Bergeron, Fabien Milliat, Eric Deutsch, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2017
Neutrophils, a candidate biomarker and target for radiation therapy?Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 30, 2010
Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: still to be establishedPierre Mordant, Yohann Loriot, Yves Castier, et al.
The Lancet. Oncology|August 1, 2019
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapyEric Deutsch, Cyrus Chargari, Lorenzo Galluzzi, et al.
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Seminars in Radiation Oncology|September 14, 2016
Successes and Failures of Combined Modality Therapies in Head and Neck CancerDaniel W Bowles, Eric Deutsch, David Raben
Plos One|January 31, 2015
Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migrationAdnan Arshad, Eric Deutsch, Marie-Catherine Vozenin
Medecine Sciences : M/S|April 24, 2026
[The radio-induced antitumor immune response as a therapeutic target]Valentin Monteiro, Michèle Mondini, Eric Deutsch, et al.
The Lancet. Oncology|April 3, 2025
Innovative, early-phase clinical trials of drug-radiotherapy combinationsAntonin Levy, Christophe Massard, Stefan Michiels, et al.
Internal and Emergency Medicine|September 10, 2015
Ultrasound guided chest tube placement for basilar pneumothoraxEric Deutsch, Sierra Beck, Jehangir Meer, et al.
Lancet (London, England)|January 6, 2018
Concerns about cardiotoxicity in the HERA trialAntonin Levy, Cyrus Chargari, Eric Deutsch, et al.
Oncoimmunology|November 26, 2024
Heterogeneous intratumor irradiation: a new partner for immunotherapyPaul Bergeron, Fabien Milliat, Eric Deutsch, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2017
Neutrophils, a candidate biomarker and target for radiation therapy?Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 30, 2010
Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: still to be establishedPierre Mordant, Yohann Loriot, Yves Castier, et al.
The Lancet. Oncology|August 1, 2019
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapyEric Deutsch, Cyrus Chargari, Lorenzo Galluzzi, et al.
Pageof 35